August 21, 2014 7:49 AM ET

Capital Markets

Company Overview of Excel Venture Management

Executive Profile

James J. Collins Ph.D.

Founder and Chairman of Scientific Advisory Board, Novophage, Inc.
AgeTotal Calculated CompensationThis person is connected to 7 Board Members in 7 different organizations across 7 different industries.

See Board Relationships
----

Background

Dr. James J. Collins, also known as Jim, Ph.D. is Technical Advisor of Joule Unlimited, Inc. Dr. Collins is a Co-Founder and SAB Member of Cellicon Biotechnologies. Dr. Collins is Founder and Chairman of Scientific Advisory Board at Novophage, Inc. Dr. Collins was also an Advisor at PureTech Ventures. He serves as a Member of Board of Strategic Advisors at Excel Venture Management and advises on several initiatives. Dr. Collins served as Co-Chairman of Scientific Advisory ...

Corporate Headquarters

800 Boylston Street
Boston, Massachusetts 02199

United States

Phone: 617-450-9800
Fax: 617-450-9749

Board Members Memberships

There is no Board Members Memberships data available.

Education

BA 1987
College of the Holy Cross
Doctorate
University of Oxford

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

There is no Total Compensation data available.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Excel Venture Management, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.